Evidence map›Paper›PMID 31576000›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2020

Vancomycin drug monitoring in infants with CoNS sepsis-target attainment, microbiological response and nephrotoxicity.

Isabelle Viel-Thériault, Brigitte Martin, Félix Thompson-Desormeaux, Julie Blackburn, Ahmed Moussa, Julie Autmizguine

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. State of Vancomycin Dosing in Neonates: An Overview.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Isabelle Viel-ThériaultDepartment of Pediatrics, Centre Hospitalier de l'Université Laval, Québec, QC, Canada. Isabelle.viel-theriault.1@ulaval.ca.ORCID http://orcid.org/0000-0001-7120-9408
Brigitte MartinDepartment of Pharmacy, CHU Sainte-Justine, Montreal, QC, Canada.
Félix Thompson-DesormeauxDepartment of Pharmacy, CHU Sainte-Justine, Montreal, QC, Canada.ORCID http://orcid.org/0000-0002-5403-9934
Julie BlackburnDepartment of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montreal, QC, Canada.
Ahmed MoussaDepartment of Pediatrics, Université de Montréal, Montreal, QC, Canada.
Julie AutmizguineDepartment of Pediatrics, Université de Montréal, Montreal, QC, Canada.
Centre Hospitalier Universitaire Sainte-Justine · CACentre hospitalier de l'Université Laval · CAUniversité de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo characterize residual vancomycin concentrations (Cmin) and assess the relationships between Cmin, the risk of nephrotoxicity and persistent CoNS sepsis.

methodsIn this 5-year retrospective study among infants treated with vancomycin, the primary outcome was the proportion of those with a steady state Cmin between 10 and 20 mg/L. The secondary outcomes were nephrotoxicity and persistent CoNS sepsis.

resultsOf 120 infants included, the median first steady state Cmin was 12.4 mg/L and 77 (64%) had a Cmin between 10 and 20 mg/L. Six percent developed nephrotoxicity. This risk was not associated with Cmin. Of the 30 infants with CoNS sepsis, 17 (57%) had persistent bacteremia, and this risk did not correlate significantly with Cmin, CoNS minimal inhibitory concentration (MIC) for vancomycin, or Cmin/MIC.

conclusionsThe majority of infants achieved targeted levels of vancomycin, but persistent bacteremia was common. We did not identify a Cmin threshold associated with nephrotoxicity, nor with microbiological clearance.

Indexed as

Drug MonitoringAnti-Bacterial AgentsArea Under CurveBacteremiaHumansInfant, NewbornRetrospective StudiesStaphylococcal InfectionsStaphylococcusStaphylococcus aureusVancomycinAnti-Bacterial AgentsVancomycin

Identifiers

PMID31576000
OpenAlexW2978575921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.